Logo image of BFX

BOWFLEX INC (BFX) Stock Fundamental Analysis

NYSE:BFX - New York Stock Exchange, Inc. - US63910B1026 - Common Stock - Currency: USD

0.195  +0 (+0.52%)

After market: 0.185 -0.01 (-5.13%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BFX. BFX was compared to 30 industry peers in the Leisure Products industry. BFX may be in some trouble as it scores bad on both profitability and health. BFX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BFX had negative earnings in the past year.
BFX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BFX reported negative net income in multiple years.
In multiple years BFX reported negative operating cash flow during the last 5 years.
BFX Yearly Net Income VS EBIT VS OCF VS FCFBFX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

BFX's Return On Assets of -51.84% is on the low side compared to the rest of the industry. BFX is outperformed by 87.88% of its industry peers.
BFX has a Return On Equity of -512.95%. This is amonst the worse of the industry: BFX underperforms 87.88% of its industry peers.
Industry RankSector Rank
ROA -51.84%
ROE -512.95%
ROIC N/A
ROA(3y)-17.6%
ROA(5y)-18.09%
ROE(3y)-48.86%
ROE(5y)-48.19%
ROIC(3y)N/A
ROIC(5y)N/A
BFX Yearly ROA, ROE, ROICBFX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

With a Gross Margin value of 20.62%, BFX is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BFX has declined.
The Profit Margin and Operating Margin are not available for BFX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.26%
GM growth 5Y-18.43%
BFX Yearly Profit, Operating, Gross MarginsBFX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

3

2. Health

2.1 Basic Checks

BFX does not have a ROIC to compare to the WACC, probably because it is not profitable.
BFX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BFX has been increased compared to 5 years ago.
BFX has a worse debt/assets ratio than last year.
BFX Yearly Shares OutstandingBFX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
BFX Yearly Total Debt VS Total AssetsBFX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 0.84, we must say that BFX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.84, BFX is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
BFX has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
BFX's Debt to FCF ratio of 1.69 is fine compared to the rest of the industry. BFX outperforms 69.70% of its industry peers.
A Debt/Equity ratio of 1.68 is on the high side and indicates that BFX has dependencies on debt financing.
The Debt to Equity ratio of BFX (1.68) is worse than 81.82% of its industry peers.
Although BFX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 1.68
Debt/FCF 1.69
Altman-Z 0.84
ROIC/WACCN/A
WACC9.45%
BFX Yearly LT Debt VS Equity VS FCFBFX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

BFX has a Current Ratio of 1.39. This is a normal value and indicates that BFX is financially healthy and should not expect problems in meeting its short term obligations.
BFX has a Current ratio of 1.39. This is amonst the worse of the industry: BFX underperforms 81.82% of its industry peers.
A Quick Ratio of 0.73 indicates that BFX may have some problems paying its short term obligations.
The Quick ratio of BFX (0.73) is worse than 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.73
BFX Yearly Current Assets VS Current LiabilitesBFX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.73% over the past year.
BFX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.02%.
BFX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.72% yearly.
EPS 1Y (TTM)37.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168.57%
Revenue 1Y (TTM)-33.02%
Revenue growth 3Y-2.49%
Revenue growth 5Y-6.72%
Sales Q2Q%-31.13%

3.2 Future

Based on estimates for the next years, BFX will show a very strong growth in Earnings Per Share. The EPS will grow by 32.86% on average per year.
The Revenue is expected to decrease by -7.30% on average over the next years.
EPS Next Y64.48%
EPS Next 2Y32.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-18.7%
Revenue Next 2Y-7.3%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BFX Yearly Revenue VS EstimatesBFX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
BFX Yearly EPS VS EstimatesBFX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

BFX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BFX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BFX Price Earnings VS Forward Price EarningsBFX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

BFX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BFX is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.47
EV/EBITDA N/A
BFX Per share dataBFX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

BFX's earnings are expected to grow with 32.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.86%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BFX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOWFLEX INC

NYSE:BFX (3/4/2024, 8:04:01 PM)

After market: 0.185 -0.01 (-5.13%)

0.195

+0 (+0.52%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)02-21 2024-02-21/bmo
Earnings (Next)05-21 2024-05-21/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.89%
Ins Owner Change0%
Market Cap7.10M
Analysts76.67
Price Target1.3 (566.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-111.22%
Min EPS beat(2)-190.84%
Max EPS beat(2)-31.6%
EPS beat(4)1
Avg EPS beat(4)-39.88%
Min EPS beat(4)-190.84%
Max EPS beat(4)65.99%
EPS beat(8)3
Avg EPS beat(8)-41.72%
EPS beat(12)6
Avg EPS beat(12)-21.76%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.31%
Min Revenue beat(2)-13.74%
Max Revenue beat(2)-12.89%
Revenue beat(4)1
Avg Revenue beat(4)-3.94%
Min Revenue beat(4)-13.74%
Max Revenue beat(4)18.67%
Revenue beat(8)2
Avg Revenue beat(8)-3.04%
Revenue beat(12)4
Avg Revenue beat(12)-0.17%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-28.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 0.47
P/OCF 0.36
P/B 0.5
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)-2.03
EYN/A
EPS(NY)-0.77
Fwd EYN/A
FCF(TTM)0.42
FCFY214.78%
OCF(TTM)0.54
OCFY279.04%
SpS6.22
BVpS0.39
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -51.84%
ROE -512.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.62%
FCFM 6.73%
ROA(3y)-17.6%
ROA(5y)-18.09%
ROE(3y)-48.86%
ROE(5y)-48.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.26%
GM growth 5Y-18.43%
F-Score5
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 1.68
Debt/FCF 1.69
Debt/EBITDA N/A
Cap/Depr 36.78%
Cap/Sales 2.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 0.73
Altman-Z 0.84
F-Score5
WACC9.45%
ROIC/WACCN/A
Cap/Depr(3y)123.01%
Cap/Depr(5y)113.84%
Cap/Sales(3y)2.79%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-168.57%
EPS Next Y64.48%
EPS Next 2Y32.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.02%
Revenue growth 3Y-2.49%
Revenue growth 5Y-6.72%
Sales Q2Q%-31.13%
Revenue Next Year-18.7%
Revenue Next 2Y-7.3%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y110.85%
FCF growth 3YN/A
FCF growth 5Y-27.62%
OCF growth 1Y114.31%
OCF growth 3YN/A
OCF growth 5Y-11.69%